Northwestern University Feinberg School of Medicine

Gemma Carvill Lab

Our Mission

The primary goal of our research is to use gene discovery and molecular biology approaches to identify new treatments for epilepsy. We aim to 1) identify the genetic causes of epilepsy, 2) use stem cell models to understand how genetic mutations can cause epilepsy, 3) develop and test new therapeutics for this condition. Our work is based on the promise of precision medicine where knowledge of an individual’s genetic makeup shapes a personalized approach to care and management of epilepsy.

Recent publications

Corbett MA, Bellows ST, Li M, Carroll R, Micallef S, Carvill GL, Myers CT, Howell KB, Maljevic S, Lerche H, Gazina EV, Mefford HC, Bahlo M, Berkovic SF, Petrou S, Scheffer IE, Gecz J  Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy.Neurology  2016 Nov 08;87(19):1975-1984

Carvill GL, Mefford HC  Next-Generation Sequencing in Intellectual Disability.J Pediatr Genet  2015 Sep;4(3):128-35. doi:10.1055/s-0035-1564439

News

  • Carvill lab opens October 2016
  • We are seeking enthusiastic team members to join the fight on epilepsy. See our research and career opportunities for more information.

Gemma L Carvill, PhD

Gemma L Carvill, PhD
Assistant Professor
Ken and Ruth Davee Department of Neurology
Department of Pharmacology
Center for Genetic Medicine

Quick links

Support Carvill Lab Research